Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

Size: px
Start display at page:

Download "Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study"

Transcription

1 Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study Hidenori Arai 1, Yoshihiro Kokubo 2, Makoto Watanabe 2, Tatsuya Sawamura 3, Tomonori Okamura 4, and Yoshihiro Miyamato 2 1 Department of Human Health Sciences, Kyoto University Graduate School of Medicine 2 Department of Preventive Cardiology, 3 Department of Vascular Physiology, National Cerebral and Cardiovascular Center 4 Department of Preventive Medicine and Public Health, School of Medicine, Keio University

2 Abstract Background and aim: Increased plasma low-density lipoprotein (LDL) cholesterol (LDL-C) concentrations have been shown to be a significant risk factor for coronary artery disease (CAD). Clinical evidence also indicated that small dense LDL (sd-ldl) particles are more atherogenic than large buoyant LDL particles. Because there was no easy assay to measure the amount of sd-ldl, no study has addressed the association between sd-ldl and cardiovascular disease. Therefore, we examined the association between sd-ldl cholesterol (sd-ldl-c) and CAD using a new assay kit for sd-ldl-c in an urban Japanese cohort. Methods: The Suita study is an 11.7-year prospective study in an urban population aged without history of myocardial infarction or stroke. Direct LDL-C and sd-ldl-c were measured in samples from 2034 participants (968 men and 1066 women) by a kit based on the precipitation method with filtration. We calculated the multivariable-adjusted hazard ratios (HRs) of sd-ldl-c and sd-ldl/ldl ratio for CAD using a proportional hazards regression model after adjusting for age, sex, hypertension, diabetes, use of lipid lowering agent, body mass index (BMI), current smoking, and alcohol drinking. Results: We divided men and women to 4 groups according to the quartiles of sd-ldl-c. Levels of sd-ldl-c were positively associated with total cholesterol, triglyceride, BMI, blood pressure, and were negatively correlated with HDL-cholesterol both in men and women. Levels of sd-ldl-c were positively correlated with age only in women. After adjusting age and sex, increasing quartiles of sd-ldl-c were associated with increased incidence of CAD (p=0.001). The HR of the 4th quartile was 3.35 (95% confidence intervals [95% CI]: ). In multivariable adjustment, the HR of the 4th quartile was almost similar. Sex-specific analysis showed that the association between sd-ldl-c and CAD was statistically significant in men, but not in women. We also found that sd- LDL/LDL ratio was a significant risk for CAD after age and sex- and multivariable-adjustment (p=0.001, 0.005, respectively). Furthermore, higher sd-ldl/ldl ratios were significantly associated with CAD even after LDL-C adjustment. Conclusions: We demonstrated that sd-ldl-c and sd-ldl/ldl are significantly associated with the development of CAD in Japanese without history of myocardial infarction or stroke. Our data indicate that sd-ldl-c is an independent and new risk factor for CAD and should be incorporated for a risk assessment. However, a larger study should be done to show the role of sd-ldl on CAD in women.

3 Background Compared to large, buoyant LDL, small dense LDL (sd-ldl) particles exhibit a prolonged plasma residence time, increased penetration into the arterial wall, lower affinity for the LDL receptor, and increased susceptibility to oxidation. Thus, sd-ldl particles possess an elevated atherogenic potential. However, few prospective studies have been done to address the role of sd-ldl in the development of cardiovascular disease.

4 Aims Address whether sd-ldl cholesterol can predict the development of CAD in a large cohort study of Japan, the Suita study.

5 Methods The Suita study, a cohort study for CVD of urban residents was established in men and women aged years had a baseline survey at the National Cerebral and Cardiovascular Center between September 1989 and March For the purposes of this study, we used archived plasma samples that had been frozen at 80 o C for the assessment of direct LDL-C and sd-ldl-c by automated standardized enzymatic analysis on a Hitachi 911 automated analyzer. The kits used for these tests (LDL-C and sd-ldl-c) were provided by Denka Seiken, Tokyo, Japan.

6 Principle of the homogeneous assay for sd LDL-C TRL lb-ldl sd-ldl HDL R1 Surfactant A Sphingomyelinase Surfactant B Surfactant A React and Eliminate React and Eliminate Protect React and Eliminate Cholesterol Cholesterol Cholesterol Cholesterol Esterase Cholesterol Oxidase Catalase Cholesterol Esterase Cholesterol Oxidase Catalase 2H 2 O + O 2 2H 2 O + O 2 2H 2 O + O 2 R2 Purple-red color Measurement H 2 O 2 Cholesterol Esterase Cholesterol Oxidase peroxidase Cholesterol sd-ldl

7 Results

8 1. Baseline Characteristic of Cardiovascular Risk Factors According to Small-dense LDL Cholesterol Quartiles in Men Men Small-dense LDL Cholesterol Q1 Q2 Q3 Q4 Number of subjects Small-dence LDL, range (mean), mg/dl (21.1) (32.7) (45.3) (67.3) P value for Trend Age, year 60.9± ± ± ± Body mass index, kg/m^2 21.5± ± ± ±2.7 <0.001 TC, mg/dl 170±25 189±24 199±25 220±27 <0.001 HDL-C, mg/dl 60±15 57±14 51±11 48±11 <0.001 LDL, mg/dl 86±20 111±21 124±23 140±26 <0.001 Large-LDL, mg/dl 65±17 78±21 79±22 72±24 <0.001 Sd-LDL/LDL ratio 0.25± ± ± ±0.11 <0.001 Blood pressure category, % Optimal blood pressure Normal blood pressure High-normal blood pressure Hypertension grade I-III Antilipidemic drug use, % Diabetes, % Current Smoking, % Current Drinking, %

9 2. Baseline Characteristic of Cardiovascular Risk Factors According to Small-dense LDL Cholesterol Quartiles in Women Women Small-dense LDL Cholesterol Q1 Q2 Q3 Q4 Number of subjects Small-dence LDL, range (mean), mg/dl (18.7) (28.6) (38.5) (59.7) P value for Trend Age, year 51.7± ± ± ±9.1 <0.001 Body mass index, kg/m^2 21.0± ± ± ±2.8 <0.001 TC, mg/dl 175±23 200±22 216±25 234±32 <0.001 HDL-C, mg/dl 67±13 64±12 60±13 54±12 <0.001 LDL, mg/dl 83±17 109±17 130±18 153±30 <0.001 Large-LDL, mg/dl 64±14 81±15 92±17 93±25 <0.001 Sd-LDL/LDL ratio 0.23± ± ± ±0.08 <0.001 Blood pressure category, % <0.001 Optimal blood pressure Normal blood pressure High-normal blood pressure Hypertension grade I-III Antilipidemic drug use, % Diabetes, % <0.001 Current Smoking, % Current Drinking, %

10 3. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to small dense LDL cholesterol quartiles Small dense LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men and women Person-years 5,593 5,773 5,597 5,739 Cardiovascular disease Case Age-adjusted ( ) 1.11 ( ) 1.64 ( ) Multivariable-adjusted ( ) 1.08 ( ) 1.60 ( ) Stroke Case Age-adjusted ( ) 0.80 ( ) 1.21 ( ) Multivariable-adjusted ( ) 0.79 ( ) 1.19 ( ) Cerebral infarction Case Age-adjusted ( ) 1.14 ( ) 1.74 ( ) Multivariable-adjusted ( ) 1.16 ( ) 1.85 ( ) Coronary heart disease Case Age-adjusted ( ) 2.26 ( ) 3.35 ( ) Multivariable-adjusted ( ) 2.17 ( ) 3.26 ( ) 0.003

11 4. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to small dense LDL cholesterol quartiles in men Small dense LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men, range Person-years 1,990 2,488 2,457 3,306 Cardiovascular disease Case Age-adjusted ( ) 1.28 ( ) 1.62 ( ) Multivariable-adjusted ( ) 1.32 ( ) 1.85 ( ) Stroke Case Age-adjusted ( ) 0.99 ( ) 1.05 ( ) Multivariable-adjusted ( ) 1.11 ( ) 1.22 ( ) Cerebral infarction Case Age-adjusted ( ) 1.13 ( ) 1.30 ( ) Multivariable-adjusted ( ) 1.18 ( ) 1.43 ( ) Coronary heart disease Case Age-adjusted ( ) 2.28 ( ) 3.50 ( ) Multivariable-adjusted ( ) 2.16 ( ) 3.96 ( ) 0.004

12 5. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to small dense LDL cholesterol quartiles in women Small dense LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Women, range Person-years 3,603 3,285 3,140 2,432 Cardiovascular disease Case Age-adjusted ( ) 0.91 ( ) 1.77 ( ) Multivariable-adjusted ( ) 0.80 ( ) 1.41 ( ) Stroke Case Age-adjusted ( ) 0.61 ( ) 1.57 ( ) Multivariable-adjusted ( ) 0.57 ( ) 1.32 ( ) Cerebral infarction Case Age-adjusted ( ) 1.31 ( ) 3.91 ( ) Multivariable-adjusted Coronary heart disease Case Age-adjusted ( ) 2.25 ( ) 2.82 ( ) Multivariable-adjusted

13 6. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to large dense LDL cholesterol quartiles Large buoyant LDL Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men and women Person-years 5,707 5,828 6,053 5,934 Cardiovascular disease Case Age-adjusted ( ) 0.70 ( ) 1.00 ( ) Multivariable-adjusted ( ) 0.73 ( ) 1.01 ( ) Stroke Case Age-adjusted ( ) 0.61 ( ) 0.82 ( ) Multivariable-adjusted ( ) 0.68 ( ) 0.88 ( ) Cerebral infarction Case Age-adjusted ( ) 0.83 ( ) 0.79 ( ) Multivariable-adjusted ( ) 0.91 ( ) 0.83 ( ) Coronary heart disease Case Age-adjusted ( ) 0.83 ( ) 1.31 ( ) Multivariable-adjusted ( ) 0.81 ( ) 1.20 ( ) 0.801

14 7. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to sdldl/ldl ratio quartiles Ratio of small dense LDL and LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men and women Person-years 5,627 5,735 5,646 5,625 Cardiovascular disease Case Age-adjusted ( ) 1.58 ( ) 2.82 ( ) <0.001 Multivariable-adjusted ( ) 1.59 ( ) 2.51 ( ) Stroke Case Age-adjusted ( ) 1.82 ( ) 2.88 ( ) Multivariable-adjusted ( ) 1.81 ( ) 2.46 ( ) Cerebral infarction Case Age-adjusted ( ) 3.02 ( ) 2.96 ( ) Multivariable-adjusted ( ) 2.93 ( ) 2.70 ( ) Coronary heart disease Case Age-adjusted ( ) 1.30 ( ) 2.86 ( ) Multivariable-adjusted ( ) 1.31 ( ) 2.76 ( ) 0.005

15 8. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to sdldl/ldl ratio quartiles in men Ratio of small dense LDL and LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men Person-years 1,885 2,015 2,573 3,768 Cardiovascular disease Case Age-adjusted ( ) 1.46 ( ) 2.28 ( ) Multivariable-adjusted ( ) 1.64 ( ) 2.26 ( ) Stroke Case Age-adjusted ( ) 1.45 ( ) 1.67 ( ) Multivariable-adjusted ( ) 1.64 ( ) 1.64 ( ) Cerebral infarction Case Age-adjusted ( ) 2.06 ( ) 1.53 ( ) Multivariable-adjusted ( ) 2.23 ( ) 1.50 ( ) Coronary heart disease Case Age-adjusted ( ) 1.63 ( ) 4.01 ( ) Multivariable-adjusted ( ) 1.73 ( ) 4.38 ( ) 0.019

16 9. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to sdldl/ldl ratio quartiles in women Ratio of small dense LDL and LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Women Person-years 3,742 3,720 3,073 1,857 Cardiovascular disease Case Age-adjusted ( ) 1.71 ( ) 4.18 ( ) Multivariable-adjusted ( ) 1.74 ( ) 3.60 ( ) Stroke Case Age-adjusted ( ) 3.02 ( ) 9.04 ( ) Multivariable-adjusted Cerebral infarction Case Age-adjusted Multivariable-adjusted Coronary heart disease Case Age-adjusted ( ) 1.19 ( ) 2.23 ( ) Multivariable-adjusted ( ) 1.19 ( ) 1.58 ( ) 0.206

17 10. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to LDL cholesterol quartiles LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men and women Person-years 5,591 5,675 5,715 5,684 Cardiovascular disease Case Age-adjusted ( ) 0.82 ( ) 1.34 ( ) Multivariable-adjusted ( ) 0.91 ( ) 1.30 ( ) Stroke Case Age-adjusted ( ) 0.62 ( ) 1.08 ( ) Multivariable-adjusted ( ) 0.71 ( ) 1.12 ( ) Cerebral infarction Case Age-adjusted ( ) 0.96 ( ) 1.11 ( ) Multivariable-adjusted ( ) 1.08 ( ) 1.15 ( ) Coronary heart disease Case Age-adjusted ( ) 1.28 ( ) 1.99 ( ) Multivariable-adjusted ( ) 1.41 ( ) 1.76 ( ) 0.107

18 11. Age- and Multivariate-adjusted Hazard Ratios for the incidence of CVD according to LDL cholesterol quartiles in men LDL Cholesterol Q1 (Lower) Q2 Q3 Q4 (Higher) P for trend Men Person-years 2,561 2,694 2,641 2,377 Cardiovascular disease Case Age-adjusted ( ) 1.08 ( ) 1.66 ( ) Multivariable-adjusted ( ) 1.26 ( ) 1.83 ( ) Stroke Case Age-adjusted ( ) 0.89 ( ) 1.11 ( ) Multivariable-adjusted ( ) 1.17 ( ) 1.42 ( ) Cerebral infarction Case Age-adjusted ( ) 1.10 ( ) 1.08 ( ) Multivariable-adjusted ( ) 1.30 ( ) 1.15 ( ) Coronary heart disease Case Age-adjusted ( ) 1.53 ( ) 2.98 ( ) Multivariable-adjusted ( ) 1.73 ( ) 2.96 ( ) 0.017

19 Summary This study showed an increased risk of CAD attributed to elevated sd-ldl-c concentrations in a Japanese population without previous history of CVD. Sd-LDL-C/LDL-C is also a significant predictor for CAD both in men and women.

20 Conclusions In this large urban cohort study conducted in Japan, we demonstrated that sd-ldl-c and sd-ldl-c/ldl-c are significantly associated with the development of CAD, providing evidence of sd-ldl-c as an important biomarker to predict CAD. A large intervention study is required to address the target goal of sd- LDL-C.

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING REAGENTS RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING Randox sdldl Cholesterol (sdldl-c) Size Matters: The True Wight of Risk in Lipid Profiling 1. BACKGROUND

More information

Lipoprotein Particle Profile

Lipoprotein Particle Profile Lipoprotein Particle Profile 50% of people at risk for HEART DISEASE are not identified by routine testing. Why is LPP Testing The Most Comprehensive Risk Assessment? u Provides much more accurate cardiovascular

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart Online publication March 25, 2009 48 6 2007 2007 HDL-C LDL-C HDL-C J Jpn Coll Angiol, 2008, 48: 463 470 NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart 1987 NIPPON DATA80 Iso 10 MRFIT

More information

Small Dense LDL Cholesterol is a Promising Biomarker for Secondary Prevention

Small Dense LDL Cholesterol is a Promising Biomarker for Secondary Prevention GGI-0624-2017 Small Dense LDL Cholesterol is a Promising Biomarker for Secondary Prevention in Elder Men with Stable Coronary Artery Disease A short running title Small Dense LDL for Secondary Prevention

More information

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both Lluís Masana Vascular Medicine and Metabolism Unit. Sant Joan University Hospital. IISPV. CIBERDEM Rovira i Virgili

More information

Supplementary information for: A functional variation in BRAP confers risk of myocardial infarction in Asian populations

Supplementary information for: A functional variation in BRAP confers risk of myocardial infarction in Asian populations Supplementary information for: A functional variation in BRAP confers risk of myocardial infarction in Asian populations Kouichi Ozaki 1, Hiroshi Sato 2, Katsumi Inoue 3, Tatsuhiko Tsunoda 4, Yasuhiko

More information

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease

Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner

More information

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk? Michael Davidson M.D. FACC, Diplomate of the American Board of Lipidology Professor,

More information

Tracking a Killer Molecule

Tracking a Killer Molecule Tracking a Killer Molecule Mercodia Oxidized LDL ELISA www.mercodia.com Mercodia Oxidized LDL ELISA products Product Catalog No Kit size Oxidized LDL ELISA 10-1143-01 96 wells Oxidized LDL competitive

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

LIPOPROTEIN PROFILING

LIPOPROTEIN PROFILING LIPOPROTEIN PROFILING in CLINICAL DIAGNOSTICS and LIFE SCIENCE RESEARCH Product Information, March 2015 2004-2015, numares HEALTH LIPOPROTEINS AND CARDIOVASCULAR DISEASE High blood cholesterol is a well-known

More information

Estimation of glucose in blood serum

Estimation of glucose in blood serum Estimation of glucose in blood serum Enzymatic estimation of glucose uses a reagent containing two enzymes and a chromogen. Glucose oxidase catalyses the oxidation of glucose to gluconolactone with the

More information

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk The New Gold Standard for Lipoprotein Analysis Advanced Testing for Cardiovascular Risk Evolution of Lipoprotein Testing The Lipid Panel Total Cholesterol = VLDL + LDL + HDL Evolution of Lipoprotein Testing

More information

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,

More information

ZEUS Trial ezetimibe Ultrasound Study

ZEUS Trial ezetimibe Ultrasound Study Trial The lower, The better Is it True for Plaque Regression? Statin alone versus Combination of Ezetimibe and Statin Juntendo University, Department of Cardiology, Tokyo, Japan Katsumi Miyauchi, Naohisa

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017

Disclosures. Background 1 What is Known MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES. Background 2 What is Not Known 10/2/2017 Disclosures MENOPAUSE, ESTROGENS, AND LIPOPROTEIN PARTICLES Grants: NIH, Quest Diagnostics Consultant: Quest Diagnostics Merck Global Atherosclerosis Advisory Board Ronald M. Krauss, Children s Hospital

More information

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC

LDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES A study published in the British Medical Journal shows that not only is high LDL cholesterol not a risk factor for all-caused

More information

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart. Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not

More information

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein

More information

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men:

Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: Glycemic index, glycemic load, and the risk of acute myocardial infarction in middle-aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study Jaakko Mursu, Jyrki K. Virtanen, Tiina H. Rissanen,

More information

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures Lipoprotein (a): Should We Measure? Should We Treat? Joseph P. McConnell, Ph.D. DABCC Health Diagnostic Laboratory Inc. Baptist Health South Florida Eleventh Annual Cardiovascular Disease Prevention International

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

BCH 447. Triglyceride Determination in Serum

BCH 447. Triglyceride Determination in Serum BCH 447 Triglyceride Determination in Serum Introduction: Triglycerides are esters of fatty acids and are hydrolyzed by lipase to glycerol and free fatty acids. Triglyceride determinations when performed

More information

Triglyceride determination

Triglyceride determination Triglyceride determination Introduction: - Triglycerides are esters of fatty acids and are hydrolyzed to glycerol and free fatty acids (by lipase) - Triglyceride determinations when performed in conjunction

More information

Supplement materials:

Supplement materials: Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction

More information

Metabolism and Atherogenic Properties of LDL

Metabolism and Atherogenic Properties of LDL Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal

More information

Fasting or non fasting?

Fasting or non fasting? Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues

More information

Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. 4

Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan. 4 146 Journal of Atherosclerosis and Thrombosis Original Articles Vol. 11, No. 3 Clinical Features of Familial Hypercholesterolemia in Japan in a Database from 1996 1998 by the Research Committee of the

More information

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence

More information

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee

More information

sphingotest vr-hgh Risk Prediction of Incident Cardiovascular Disease

sphingotest vr-hgh Risk Prediction of Incident Cardiovascular Disease sphingotest vr-hgh Risk Prediction of Incident Cardiovascular Disease Human Growth Hormone as Vascular Risk Biomarker sphingotec offers the vascular risk human Growth Hormone biomarker (vr-hgh) for the

More information

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan.

Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Manabu Izumi, Kazuo Suzuki, Tetsuya Sakamoto and Masato Hayashi Jichi Medical University

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

CVD Prevention, Who to Consider

CVD Prevention, Who to Consider Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..

More information

Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up

Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up 1169 Original Article Hypertens Res Vol.30 (2007) No.12 p.1169-1175 Joint Impact of Smoking and Hypertension on Cardiovascular Disease and All-Cause Mortality in Japan: NIPPON DATA80, a 19-Year Follow-Up

More information

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study 1/5 Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study Jennifer S. Lee, Po-Yin Chang, Ying Zhang, Jorge

More information

Life Science Journal 2018;15(12)

Life Science Journal 2018;15(12) Multicenter observational study of risk factors profile in a sample of Egyptian Patients with Acute Coronary Syndrome (part of Egyptian Cardiovascular Risk Factors Project) Prof. Dr. Ahmed Ashraf Reda,

More information

Declaration of conflict of interest. Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV

Declaration of conflict of interest. Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV Declaration of conflict of interest Dominique de Kleijn is founder of a UMC Utrecht spin-off biomarker company Cavadis BV BIOMARKERS OF DISEASE Microvesicle proteins as diagnostic and predictive biomarkers

More information

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Original Research Article A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Deepa Kalikavil Puthenveedu 1, Sundaraj

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Correlation of novel cardiac marker

Correlation of novel cardiac marker Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely

More information

Welcome and Introduction

Welcome and Introduction Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Impact of Chronicity on Lipid Profile of Type 2 Diabetics

Impact of Chronicity on Lipid Profile of Type 2 Diabetics Impact of Chronicity on Lipid Profile of Type 2 Diabetics Singh 1, Gurdeep & Kumar 2, Ashok 1 Ph.D. Research Scholar, Department of Sports Science, Punjabi University Patiala, India, Email: drgurdeep_sahni@yahoo.co.in

More information

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School

Kathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review

More information

Lipid/Lipoprotein Structure and Metabolism (Overview)

Lipid/Lipoprotein Structure and Metabolism (Overview) Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures

More information

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:

More information

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU

High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU ESC Congress 2011 Paris, France, August 27-31 KAROLA Session: Prevention: Are biomarkers worth their money? Abstract # 84698 High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients

More information

Dysfunctional HDL and Coronary Artery Disease (CAD) UMHS-PUHSC JOINT INSTITUTE

Dysfunctional HDL and Coronary Artery Disease (CAD) UMHS-PUHSC JOINT INSTITUTE Dysfunctional HDL and Coronary Artery Disease (CAD) UMHS-PUHSC JOINT INSTITUTE PIs and Members of HDL Project Wei Gao, M.D., Ph.D. Professor and Chair Cardiology Third Hospital, PUHSC Yong Huo, M.D., Ph.D.

More information

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL

PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL Lipids are characterized by low polarity and limited solubility in water. Their plasma concentration is about 500-600

More information

Race Original cohort Clean cohort HR 95%CI P HR 95%CI P. <8.5 White Black

Race Original cohort Clean cohort HR 95%CI P HR 95%CI P. <8.5 White Black Appendix Table 1: Hazard Ratios of the association between CSCs and all-cause mortality from original cohort and the clean cohort excluding CHD/strokes. CSC categories Race Original cohort Clean cohort

More information

Eyes on Korean Data: Lipid Management in Korean DM Patients

Eyes on Korean Data: Lipid Management in Korean DM Patients Eyes on Korean Data: Lipid Management in Korean DM Patients ICDM Luncheon Symposium Sung Rae Kim MD PhD Division of Endocrinology and Metabolism The Catholic University of Korea Causes of Death in People

More information

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

doi: /j.atherosclerosis

doi: /j.atherosclerosis doi: 10.1016/j.atherosclerosis.2012.01.013 Page 1 High serum total cholesterol levels is a risk factor of ischemic stroke for general Japanese population: the JPHC study Renzhe Cui 1, Hiroyasu Iso 1, Kazumasa

More information

Metabolic Syndrome and Workplace Outcome

Metabolic Syndrome and Workplace Outcome Metabolic Syndrome and Workplace Outcome Maine Worksite Wellness Initiative June 15, 2010 Alyssa B. Schultz Dee W. Edington Current Definition* of Metabolic Syndrome At least 3 of the following: Waist

More information

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Dyslipedemia New Guidelines

Dyslipedemia New Guidelines Dyslipedemia New Guidelines New ACC/AHA Prevention Guidelines on Blood Cholesterol November 12, 2013 Mohammed M Abd El Ghany Professor of Cardiology Cairo Universlty 1 1 0 Cholesterol Management Pharmacotherapy

More information

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers

KEY COMPONENTS. Metabolic Risk Cardiovascular Risk Vascular Inflammation Markers CardioMetabolic Risk Poor blood sugar regulation and unhealthy triglyceride and lipoprotein levels often present long before the diagnosis of type 2 Diabetes. SpectraCell s CardioMetabolic and Pre-Diabetes

More information

Correlation of LV Longitudinal Strain by 2D Speckle Tracking with Cardiovascular risk in Elderly. (A pilot study of EGAT-Echo study.

Correlation of LV Longitudinal Strain by 2D Speckle Tracking with Cardiovascular risk in Elderly. (A pilot study of EGAT-Echo study. Correlation of LV Longitudinal Strain by 2D Speckle Tracking with Cardiovascular risk in Elderly. (A pilot study of EGAT-Echo study.) Researcher: Dr. Atthakorn Wutthimanop, MD. Research adviser: Dr.PrinVathesathokit,

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

BIOCHEMISTRY BLOOD - SERUM Result Range Units

BIOCHEMISTRY BLOOD - SERUM Result Range Units BIOCHEMISTRY BLOOD - SERUM Result Range Units LIPIDS CHOLESTEROL 3.9 0.0-5.5 mmol/l TRIGLYCERIDES 0.7 < 1.5 mmol/l LIPID STUDIES HDL(Protective) 1.5 > 1.2 mmol/l LDL(Atherogenic) 2.1 0.5-3.5 mmol/l Cholesterol/HDL

More information

AHA Clinical Science Special Report: November 10, 2015

AHA Clinical Science Special Report: November 10, 2015 www.canheart.ca High-density lipoprotein cholesterol and cause-specific mortality: A population-based study of more than 630,000 individuals without prior cardiovascular conditions Dennis T. Ko, MD, MSc;

More information

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009 Learning Objectives 1. Understand the role of statin therapy in the primary and secondary prevention of stroke 2. Explain

More information

Diabetic Dyslipidemia

Diabetic Dyslipidemia Diabetic Dyslipidemia Dr R V S N Sarma, M.D., (Internal Medicine), M.Sc., (Canada), Consultant Physician Cardiovascular disease (CVD) is a significant cause of illness, disability, and death among individuals

More information

Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease

Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease Policy Number: Original Effective Date: MM.02.013 02/01/2009 Line(s) of Business: Current Effective Date: HMO; PPO;

More information

The Framingham Risk Score (FRS) is widely recommended

The Framingham Risk Score (FRS) is widely recommended C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore

More information

Chapter 18. Diet and Health

Chapter 18. Diet and Health Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in

More information

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight Quest, Quest Diagnostics, the associated logo, and all associated Quest Diagnostics marks are the registered trademarks of Quest

More information

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography

Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Impact of Body Mass Index and Metabolic Syndrome on the Characteristics of Coronary Plaques Using Computed Tomography Angiography Cardiovascular Division, Faculty of Medicine, University of Tsukuba Akira

More information

Best Lipid Treatments

Best Lipid Treatments Best Lipid Treatments Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Overview of Talk Review of pathogenesis

More information

Elevated serum creatine kinase predicts first-ever myocardial infarction: a 12-year population-based cohort study in Japan, the Suita study

Elevated serum creatine kinase predicts first-ever myocardial infarction: a 12-year population-based cohort study in Japan, the Suita study Published by Oxford University Press on behalf of the International Epidemiological Association ß The Author 2009; all rights reserved. Advance Access publication 25 June 2009 International Journal of

More information

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION 1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT

More information

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use

Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Table 1 Baseline characteristics of 60 hemodialysis patients with atrial fibrillation and warfarin use Baseline characteristics Users (n = 28) Non-users (n = 32) P value Age (years) 67.8 (9.4) 68.4 (8.5)

More information

Inflammation as A Target for Therapy. Focus on Residual Inflammatory Risk

Inflammation as A Target for Therapy. Focus on Residual Inflammatory Risk ESC Rome Monday August 29, 2016 Inflammation as A Target for Therapy Focus on Residual Inflammatory Risk Paul M Ridker, MD Eugene Braunwald Professor of Medicine Harvard Medical School Director, Center

More information

Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial

Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial Sripal Bangalore, MD, MHA, Chuan-Chuan Wun, PhD, David A DeMicco, PharmD,

More information

Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date

Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Original Policy Date MP 2.04.22 Measurement of Serum Intermediate Density Lipoproteins (Remnant-like Particles) Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with

More information

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.

Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular

More information

Master Class in Preventive Cardiology. The New MI Phenotype OR. Klas Malmberg MD, PhD, FESC Karolinska Institutet, Stockholm Sweden

Master Class in Preventive Cardiology. The New MI Phenotype OR. Klas Malmberg MD, PhD, FESC Karolinska Institutet, Stockholm Sweden Master Class in Preventive Cardiology The New MI Phenotype OR Klas Malmberg MD, PhD, FESC Karolinska Institutet, Stockholm Sweden The New MI Phenotype OR Coronary disease and glucose abnormalities Klas

More information

Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease

Novel Biomarkers in Risk Assessment and Management of Cardiovascular Disease Page: 1 of 34 Last Review Status/Date: March 2016 Management of Cardiovascular Disease Description Numerous lipid and nonlipid biomarkers have been proposed as potential risk markers for cardiovascular

More information

Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference

Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal Circumference Original Asian Pacific Journal of Disease Management 2007; 1(2), 55-63 Retrospective Cohort Study for the Evaluation of Life- Style Risk Factors in Developing Metabolic Syndrome under the Estimated Abdominal

More information

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid Malaysian Journal of Medical Sciences, Vol. 11, No. 1, January 2004 (44-51) ORIGINAL ARTICLE DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul

More information

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms

Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±

More information